Sign In
29 Jul 2010 10:23
e-Therapeutics plc ('e-Therapeutics' or 'the Company')
Issue of Equity
e-Therapeutics plc (AIM: ETX), the systems biology drug discovery company, announces that on 28 July 2010, has today issued and allotted 121,780 ordinary shares of 0.1p each in the Company ('New Ordinary Shares') in order to satisfy the exercise of certain options.
Application has been made to admit the New Ordinary Shares to trading on AIM and dealings in the New Ordinary Shares are expected to commence on 2 August 2010. Following admission the number of ordinary shares in issue in the Company will be 66,008,532.
The above figure (66,008,532 ordinary shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, e-Therapeutics plc under the FSA's Disclosure and Transparency Rules.
29 July 2010
- Ends -
|
For more information: |
|
|
|
|
|
e-Therapeutics plc |
www.etherapeutics.co.uk |
|
Johnny Cordiner john.cordiner@etherapeutics.co.uk |
+44 (0) 191 233 1317 |
|
|
|
|
Nominated Advisor & Broker: Panmure Gordon |
|
|
Aubrey Powell |
+44 (0) 20 7459 5733 |
|
|
|
Follow the stocks
